![Clozapine discontinuation withdrawal symptoms in schizophrenia - Graham Blackman, Ebenezer Oloyede, 2021 Clozapine discontinuation withdrawal symptoms in schizophrenia - Graham Blackman, Ebenezer Oloyede, 2021](https://journals.sagepub.com/cms/10.1177/20451253211032053/asset/images/large/10.1177_20451253211032053-fig1.jpeg)
Clozapine discontinuation withdrawal symptoms in schizophrenia - Graham Blackman, Ebenezer Oloyede, 2021
![Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus | CNS Spectrums | Cambridge Core Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus | CNS Spectrums | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20190607063452442-0543:S1092852918001359:S1092852918001359_tab6.gif?pub-status=live)
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus | CNS Spectrums | Cambridge Core
![Psychiatric hospitalization following antipsychotic medication cessation in first episode psychosis - Joseph F Hayes, David PJ Osborn, Andreas Lundin, Christina Dalman, 2019 Psychiatric hospitalization following antipsychotic medication cessation in first episode psychosis - Joseph F Hayes, David PJ Osborn, Andreas Lundin, Christina Dalman, 2019](https://journals.sagepub.com/cms/10.1177/0269881119827883/asset/images/large/10.1177_0269881119827883-fig1.jpeg)
Psychiatric hospitalization following antipsychotic medication cessation in first episode psychosis - Joseph F Hayes, David PJ Osborn, Andreas Lundin, Christina Dalman, 2019
![Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine | BMJ Case Reports Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine | BMJ Case Reports](https://casereports.bmj.com/content/bmjcr/14/4/e242495/F1.large.jpg)
Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine | BMJ Case Reports
![Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse](https://psychscenehub.com/wp-content/uploads/2021/10/Symptoms-of-Antipsychotic-Withdrawal-Syndrome.png)
Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse
![Chouinard, 2017 Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy - From journals and scientific sources - Surviving Antidepressants Chouinard, 2017 Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy - From journals and scientific sources - Surviving Antidepressants](https://content.invisioncic.com/r138344/monthly_2018_01/image.png.5520a287d2e550469543d9dc290c909e.png)
Chouinard, 2017 Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy - From journals and scientific sources - Surviving Antidepressants
![The neurochemical mechanism of rebound psychosis in Parkinson's disease - Papapetropoulos - 2005 - Movement Disorders - Wiley Online Library The neurochemical mechanism of rebound psychosis in Parkinson's disease - Papapetropoulos - 2005 - Movement Disorders - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/e768442d-8bd1-4ce0-b538-426b177b48fa/mds.v37.10.cover.jpg?trick=1666500704667)